Skip to main content

Study on Potentiation of ATRA Activity in HL-60 Cells by Targeting Methylation Enzymes | Chapter 2 | New Frontiers in Medicine and Medical Research Vol. 11

All Trans Retinoic Acid (ATRA) is a clinically established Differentiation Inducer (DI) for Acute Promyelocytic Leukemia (APL). Its efficacy in treating other kinds of Acute Myelocytic Leukemia (AML) is limited. ATRA targets the PML-RARA (promyelocytic leukemia/retinoic acid receptor-alpha)/DNA methyltransferase (DNMT)/Histone Deacetylase (HDAC) complex in APL, causing gene silencing to be lost and Terminal Differentiation to occur (TD). ATRA targeting of WT RARA as a single drug fails to modify the epigenetic modifications that prevent differentiation in other kinds of AML. When paired with DNMT inhibitors like 5-azacytidine, however, ATRA has better in vitro and clinical effectiveness against AML. The methylation enzyme complex (MMS), which includes Methionine Adenosyltransferase (MAT), Methyltransferase (MT), and S-Adenosylhomocysteine Hydrolase (SAHH), was previously shown to trigger differentiation in the AML M2 HL-60 cell line model. Differentiation Helper Inducers are inhibitors of the ternary methylation enzyme complex (DHIs). While they can't produce significant terminal differentiation on their own, they can help DIs work better. DHIs that destabilise SAHH enhance ATRA's ability to induce terminal differentiation in both sensitive and resistant HL-60 cells in vitro, according to this study. We also looked at Tyrosine Kinase Inhibitors (TKIs), which block the generation of SAHH's stabilising factor, and steroid analogues, which compete with SAHH's endogenous steroid stabilising factor. After exposure to 1(mu)M doses of ATRA, 72 percent of early passage (sensitive) HL-60 cells displayed induction of Terminal Differentiation (TD), whereas only 43 percent of late passage (resistant) cells did. Late passage HL-60 cell TD rose dramatically when ATRA was coupled with TKI imatinib mesylate or the steroid analogues resveratrol or (beta)-sitosterol, drugs with no innate capacity to induce differentiating, reaching 98 percent, 99 percent, and 94 percent of cells, respectively. Combinations of ATRA with cytotoxic chemotherapeutic drugs resulted in very minor improvements in TD percentages: ATRA plus topotecan: 76 percent; ATRA plus oxaliplatin: 63 percent; ATRA plus paclitaxel: 59 percent. ATRA's effects on an AML M2 cell line, and possibly other kinds of AML, were amplified when it was combined with drugs that interfere with the maintenance of the methyl group pool.


Author (S) Details

Ming C. Liau
CDA Therapeutics, CA, USA.

Jai-Hyun Kim
Chao Family Comprehensive Cancer Center, University of California, IrvineMedical Center, CA, USA.

John P. Fruehauf
Chao Family Comprehensive Cancer Center, University of California, IrvineMedical Center, CA, USA.


View Book :- https://stm.bookpi.org/NFMMR-V11/article/view/3688

Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Greening Regional Airports: A Vision for Carbon Neutral Infrastructure | Chapter 12 | Contemporary Perspective on Science, Technology and Research Vol. 3

 This study provides an overview of the energy demand of a regional airport, divided into individual time horizons. The electrification of aircraft systems raises the question of whether airports will be among the largest electricity consumers in our infrastructure in the future. Sustainability and especially emission reductions are significant challenges for airports that are currently being addressed. The Clean Sky 2 project GENESIS addresses the environmental sustainability of hybrid-electric 50-passenger aircraft systems in a life cycle perspective to support the development of a technology roadmap for the transition to sustainable and competitive electric aircraft systems. This article originates from the GENESIS research and describes various options for ground power supply at a regional airport. Potential solutions for airport infrastructure with a short (2030), medium (2040), and long (2050) time horizon are proposed. In addition to the environmental and conservation benefi...
Post a Comment
Read more

Occipital Dermal Sinus Tract Causing Craniospinal Infection: A Review | Chapter 13 | New Visions in Medicine and Medical Science Vol. 4

  Dermal sinus is a rare congenital condition characterized by a pathological tract connecting the skin to deeper tissues of the central nervous system, potentially leading to severe infectious complications. It arises from a failure in the separation of ectodermal layers during early gestation. Diagnosing dermal sinus tract in newborns requires a careful physical examination, focusing on midline dimples in the occipital region associated with cutaneous abnormalities like hairy nevus or hyperpigmentation. The presence of drainage, abnormal hair distribution, or localized swelling may indicate a sinus tract. Regular examination for dimples or sinuses is recommended for infants and children with recurrent meningitis or infections. Early detection is crucial to prevent severe complications like meningitis, with Staphylococcus aureus being a common causative organism. Neuroradiological studies, including computed tomography (CT) scan and magnetic resonance imaging (MRI), with histopath...
Post a Comment
Read more

Alkali Element Modification of Glucose Molecules as a Method to Dissolve Cancer Cells | Chapter 12 | New Visions in Medicine and Medical Science Vol. 4

  The present study highlights about alkali element modification of glucose molecules as a method to dissolve cancer cells. The central regulation of the mechanisms governing cell proliferation has little effect on cancer cells. Cancer cells are entirely independent of the central command and divide and proliferate on their own, making it challenging to activate their response mechanism. Precisely, this is the reason why they are at risk to the health of humans and/or any biological entities. Instead of trying to reconnect the central command of the growth control mechanism to cancer cells that are already out of the range, we present a method of using the cancer cell’s own irresponsive and uncontrolled growth mechanism to their disadvantage and destroy the cancer cells. We found that this is achievable in an atomic/molecular level study of the glucose molecule, which is the primary food source used for growth and energy generation by all cells in the body, including the cancer cel...
Post a Comment
Read more